payor coverage New AMP Survey Reports Insufficient Reimbursement for Analysis, Interpretation of MDx Test Results The survey found analysis, interpretation, and reporting requirements can take more than six hours per test but that reimbursement for tests doesn't account for this work. Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Bio-Techne's CEO said the coverage decision will expand access to its EPI test and enable additional men to better decide whether to proceed with a prostate biopsy. German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing Premium Under the Ge-Med project, University Hospital Tübingen will offer diagnostic whole-genome sequencing for all genetic indications and will include PRS in its reporting. Genomind Receives Medicare Coverage for Pharmacogenetics Test The company said its Professional PGx Express test will now be reimbursed by Medicare, and that the VA has extended its current supply contract for the test. CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon The final decision includes some changes, most notably removing requirements for guideline inclusion, but retains its technical performance benchmarks. Jun 21, 2017 Myriad Genetics Signs Pricing Agreement With United Healthcare for Several Tests Jun 2, 2017 Myriad Genetics' EndoPredict Test Receives New Coverage From 17 Insurance Plans May 30, 2017 Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer Premium Mar 22, 2017 Good Start Genetics Signs Coverage Agreement with BCBS of Texas Mar 7, 2017 Vermillion's Aspira Labs Secures Expanded Medi-Cal Coverage for OVA1 Feb 21, 2017 Veracyte Afirma Test Gains Coverage From 10 New BCBS Plans Feb 9, 2017 Aetna to Cover NxGen MDx Genetic Testing Services Jan 31, 2017 Humana to Cover NanoString Technologies Prosigna Breast Cancer Test Jan 10, 2017 Biocept Nabs BCBS Texas In-Network Provider Agreement Jan 6, 2017 With Medicare Draft Coverage, Indi Aims to Launch Next-Gen Xpresys Lung Test by Year End Premium Jan 6, 2017 Myriad Genetics Breast Cancer Test Secures Coverage From Five BCBS Affiliates Jan 4, 2017 GenomeWeb Index Falls 3 Percent in 2016; Genmark Leads Gainers as PacBio Drops Nov 7, 2016 Breast Cancer Test Makers React to Movement in German Reimbursement Process Premium Nov 2, 2016 MDxHealth Posts Sharp Rise in Q3 Revenues Oct 27, 2016 Invitae Inks National Provider Agreement With Humana Oct 27, 2016 MDxHealth Prostate Cancer Test Gains Coverage From Health Care Services Corporation Oct 17, 2016 Exact Sciences Gets Coverage from DoD for Cologuard Screening Test Oct 6, 2016 Highmark BCBS to Cover MDxHealth Prostate Cancer Test Sep 27, 2016 Payors Prioritize Clinical Validation Studies, Guidelines in Making NIPS Coverage Decisions Premium Sep 27, 2016 Independence Blue Cross to Cover MDxHealth Prostate Cancer Test Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.